Showing results (21-30 of 435) with videos related to
Sort By:
Pageof 44
Expert Opinion on Pharmacotherapy|January 7, 2012
InforMatrix: ADP antagonists in acute coronary syndromesRobert Janknegt, Lex Ruiters, Hugo Ten CateBlood Reviews|May 2, 2013
The role of tissue factor pathway inhibitor in atherosclerosis and arterial thrombosisKristien Winckers, Hugo ten Cate, Tilman M HackengAdvances in Cardiology|August 22, 2012
Challenges in atrial fibrillationRon Pisters, Hugo Ten Cate, Harry J CrijnsThrombosis Research|March 4, 2021
Suggestions for global coagulation assays for the assessment of COVID-19 associated hypercoagulabilityTom W van de Berg, Anne-Marije M Hulshof, Magdolna Nagy, et al.Trends in Molecular Medicine|July 6, 2006
Signal transduction induced by activated protein C: no role in protection against sepsis?Sjoukje H Slofstra, Hugo ten Cate, C Arnold SpekJournal of Thrombosis and Thrombolysis|November 19, 2013
Thrombin generation and atherosclerosisJana Kalz, Hugo ten Cate, Henri M H SpronkSeminars in Thrombosis and Hemostasis|February 16, 2006
Tissue factor in infection and severe inflammationMarcel Levi, Tom van der Poll, Hugo ten CateCritical Care Medicine|May 11, 2002
Endothelium: interface between coagulation and inflammationMarcel Levi, Hugo ten Cate, Tom van der PollThrombosis Journal|August 26, 2006
Low dose endotoxin priming is accountable for coagulation abnormalities and organ damage observed in the Shwartzman reaction. A comparison between a single-dose endotoxemia model and a double-hit endotoxin-induced Shwartzman reactionSjoukje H Slofstra, Hugo ten Cate, C Arnold SpekThe Hematology Journal : the Official Journal of the European Haematology Association|September 23, 2003
Disseminated intravascular coagulationSjoukje H Slofstra, C Arnold Spek, Hugo ten CatePageof 44